Literature DB >> 36178490

Fluorescent aptasensor based on conformational switch-induced hybridization for facile detection of β-amyloid oligomers.

Chun-Hsien Chen1, Yuh-Jyh Jong2,3,4,5,6, Yu-Ying Chao7, Chun-Chi Wang8,9, Yen-Ling Chen10,11,12,13.   

Abstract

Aβ oligomers (AβO) are a dominant biomarker for early Alzheimer's disease diagnosis. A fluorescent aptasensor coupled with conformational switch-induced hybridization was established to detect AβO. The fluorescent aptasensor is based on the interaction of fluorophore-labeled AβO-specific aptamer (FAM-Apt) against its partly complementary DNA sequence on the surface of magnetic beads (cDNA-MBs). Once the FAM-Apt binds to AβO, the conformational switch of FAM-Apt increases the tendency to be captured by cDNA-MBs. This causes a descending fluorescence of supernatant, which can be utilized to determine the levels of AβO. Thus, the base-pair matching above 12 between FAM-Apt and cDNA-MBs with increasing hybridizing free energies reached the ascending fluorescent signal equilibrium. The optimized aptasensor showed linearity from 1.7 ng mL-1 to 85.1 (R = 0.9977) with good recoveries (79.27-109.17%) in plasma. Furthermore, the established aptasensor possesses rational selectivity in the presence of monomeric Aβ, fibrotic Aβ, and interferences. Therefore, the developed aptasensor is capable of quantifying AβO in human plasma and possesses the potential to apply in clinical cases.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Aβ oligomers; Conformational switch–induced hybridization; Fluorescent aptasensor

Year:  2022        PMID: 36178490     DOI: 10.1007/s00216-022-04350-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  29 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

Review 3.  Alzheimer's disease.

Authors:  Alistair Burns; Steve Iliffe
Journal:  BMJ       Date:  2009-02-05

4.  High performance plasma amyloid-β biomarkers for Alzheimer's disease.

Authors:  Akinori Nakamura; Naoki Kaneko; Victor L Villemagne; Takashi Kato; James Doecke; Vincent Doré; Chris Fowler; Qiao-Xin Li; Ralph Martins; Christopher Rowe; Taisuke Tomita; Katsumi Matsuzaki; Kenji Ishii; Kazunari Ishii; Yutaka Arahata; Shinichi Iwamoto; Kengo Ito; Koichi Tanaka; Colin L Masters; Katsuhiko Yanagisawa
Journal:  Nature       Date:  2018-01-31       Impact factor: 49.962

5.  Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis.

Authors:  L Zhou; K H Chan; L W Chu; J S C Kwan; Y Q Song; L H Chen; P W L Ho; O Y Cheng; J W M Ho; K S L Lam
Journal:  Biochem Biophys Res Commun       Date:  2012-06-12       Impact factor: 3.575

6.  RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

Authors:  John E Donahue; Stephanie L Flaherty; Conrad E Johanson; John A Duncan; Gerald D Silverberg; Miles C Miller; Rosemarie Tavares; Wentian Yang; Qian Wu; Edmond Sabo; Virginia Hovanesian; Edward G Stopa
Journal:  Acta Neuropathol       Date:  2006-07-25       Impact factor: 17.088

7.  RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.

Authors:  Rashid Deane; Zhenhua Wu; Berislav V Zlokovic
Journal:  Stroke       Date:  2004-09-30       Impact factor: 7.914

8.  Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study.

Authors:  Ming-Jang Chiu; Ta-Fu Chen; Chaur-Jong Hu; Sui-Hing Yan; Yu Sun; Bing-Hsien Liu; Yun-Tsui Chang; Che-Chuan Yang; Shieh-Yueh Yang
Journal:  Nanomedicine       Date:  2020-03-25       Impact factor: 5.307

9.  Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease.

Authors:  Carol Man Gao; Alice Y Yam; Xuemei Wang; Erika Magdangal; Cleo Salisbury; David Peretz; Ronald N Zuckermann; Michael D Connolly; Oskar Hansson; Lennart Minthon; Henrik Zetterberg; Kaj Blennow; Joseph P Fedynyshyn; Sophie Allauzen
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

10.  The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes.

Authors:  Nady Braidy; Martin Zarka; Bat-Erdene Jugder; Jeffrey Welch; Tharusha Jayasena; Daniel K Y Chan; Perminder Sachdev; Wallace Bridge
Journal:  Front Aging Neurosci       Date:  2019-08-08       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.